CBD Shows Promise for Chronic Jaw and Facial Pain But Not Acute Dental Pain
A systematic review of 10 studies found CBD demonstrates analgesic, anti-inflammatory, and muscle-relaxant effects for chronic TMD and bruxism pain, particularly when applied topically, but results for acute dental pain like pulpitis or post-surgical pain were inconsistent.
Quick Facts
What This Study Found
CBD showed consistent benefits for chronic myofascial TMD and bruxism pain across clinical trials and preclinical models, particularly with topical or intraoral application. For acute nociceptive pain (pulpitis, third molar surgery), results were inconsistent. CBD enhanced conventional analgesics (opioids, NSAIDs) in preclinical models, suggesting synergistic potential.
Key Numbers
10 studies reviewed (RCTs and animal models). CBD effective for chronic myofascial TMD and bruxism. Inconsistent results for acute dental pain. CBD enhanced opioid and NSAID effects in preclinical models. Adverse effects minimal but underreported.
How They Did This
Systematic review evaluating 10 clinical and preclinical studies meeting inclusion criteria for CBD in upper-quarter pain conditions including TMDs, orofacial pain, myofascial dysfunction, and post-surgical dental pain. Studies assessed for methodological quality and risk of bias.
Why This Research Matters
This review clarifies where CBD is most and least promising for oral and facial pain — chronic muscle-related pain responds well, but acute dental pain does not. This distinction helps clinicians and patients set appropriate expectations.
The Bigger Picture
The distinction between chronic muscle pain (responsive to CBD) and acute dental pain (not consistently responsive) aligns with CBD's known mechanisms — anti-inflammatory and muscle-relaxant effects take time to build, while acute nociceptive pain requires faster, different pathways.
What This Study Doesn't Tell Us
Only 10 studies met criteria — evidence base is still small. Substantial heterogeneity in CBD dosage, formulation, routes, and outcomes. Adverse effects underreported in clinical trials. Publication bias possible.
Questions This Raises
- ?What is the optimal CBD formulation and dose for TMD?
- ?Could CBD reduce the need for opioids after dental procedures through synergistic effects?
- ?Why doesn't CBD work as well for acute dental pain?
Trust & Context
- Key Stat:
- Evidence Grade:
- Systematic review with quality assessment, but limited by the small number and heterogeneity of underlying studies.
- Study Age:
- Published 2025.
- Original Title:
- Cannabidiol for Orofacial and Upper-Quarter Pain: A Systematic Evaluation of Therapeutic Potential.
- Published In:
- Journal of clinical medicine, 14(12) (2025)
- Authors:
- Walczyńska-Dragon, Karolina(2), Fiegler-Rudol, Jakub(2), Nitecka-Buchta, Aleksandra(2), Baron, Stefan
- Database ID:
- RTHC-07900
Evidence Hierarchy
Analyzes all available research on a topic using a structured method.
What do these levels mean? →Frequently Asked Questions
Can CBD help with TMJ pain?
The evidence is promising for chronic TMD-related muscle pain, particularly with topical CBD application. Multiple studies showed analgesic, anti-inflammatory, and muscle-relaxant effects. However, more standardized research is needed before definitive recommendations.
Should I use CBD for a toothache?
This review found inconsistent evidence for CBD in acute dental pain like toothaches or post-surgical pain. CBD appears better suited for chronic muscle-related pain than acute dental conditions. Standard dental treatment remains the first-line approach.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-07900APA
Walczyńska-Dragon, Karolina; Fiegler-Rudol, Jakub; Nitecka-Buchta, Aleksandra; Baron, Stefan. (2025). Cannabidiol for Orofacial and Upper-Quarter Pain: A Systematic Evaluation of Therapeutic Potential.. Journal of clinical medicine, 14(12). https://doi.org/10.3390/jcm14124186
MLA
Walczyńska-Dragon, Karolina, et al. "Cannabidiol for Orofacial and Upper-Quarter Pain: A Systematic Evaluation of Therapeutic Potential.." Journal of clinical medicine, 2025. https://doi.org/10.3390/jcm14124186
RethinkTHC
RethinkTHC Research Database. "Cannabidiol for Orofacial and Upper-Quarter Pain: A Systemat..." RTHC-07900. Retrieved from https://rethinkthc.com/research/walczynska-dragon-2025-cannabidiol-for-orofacial-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.